107 related articles for article (PubMed ID: 18948163)
1. Identifying the profile of optimal candidates for antipsychotic depot therapy A cluster analysis.
Heres S; Hamann J; Mendel R; Wickelmaier F; Pajonk FG; Leucht S; Kissling W
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1987-93. PubMed ID: 18948163
[TBL] [Abstract][Full Text] [Related]
2. The attitude of patients towards antipsychotic depot treatment.
Heres S; Schmitz FS; Leucht S; Pajonk FG
Int Clin Psychopharmacol; 2007 Sep; 22(5):275-82. PubMed ID: 17690596
[TBL] [Abstract][Full Text] [Related]
3. Predictors for starting depot administration of risperidone in chronic users of antipsychotics.
Vehof J; Postma MJ; Bruggeman R; De Jong-Van Den Berg LT; Van Den Berg PB; Stolk RP; Burger H
J Clin Psychopharmacol; 2008 Dec; 28(6):625-30. PubMed ID: 19011430
[TBL] [Abstract][Full Text] [Related]
4. Partial compliance with antipsychotic medication is common in patients with schizophrenia.
Rummel-Kluge C; Schuster T; Peters S; Kissling W
Aust N Z J Psychiatry; 2008 May; 42(5):382-8. PubMed ID: 18473256
[TBL] [Abstract][Full Text] [Related]
5. Depot and oral antipsychotics: patient preferences and attitudes are not the same thing.
Patel MX; De Zoysa N; Bernadt M; David A
J Psychopharmacol; 2009 Sep; 23(7):789-96. PubMed ID: 18583438
[TBL] [Abstract][Full Text] [Related]
6. Attitudes towards long-acting depot antipsychotics: a survey of patients, relatives and psychiatrists.
Jaeger M; Rossler W
Psychiatry Res; 2010 Jan; 175(1-2):58-62. PubMed ID: 20004980
[TBL] [Abstract][Full Text] [Related]
7. [Compliance in the treatment of schizophrenia--project ADHES (the renewed results)].
Chadzyńska M; Meder J; Tyszkowska M
Psychiatr Pol; 2008; 42(4):561-70. PubMed ID: 19189600
[TBL] [Abstract][Full Text] [Related]
8. [Intervals between hospitalisations in schizophrenia patients under antipsychotics in depot-form versus oral second generation antipsychotics].
Gutwinski S; Müller P; Koller M
Psychiatr Prax; 2007 Sep; 34(6):289-91. PubMed ID: 17806015
[TBL] [Abstract][Full Text] [Related]
9. How much more effective do depot antipsychotics have to be compared to oral antipsychotics before they are prescribed?
Hamann J; Mendel R; Heres S; Leucht S; Kissling W
Eur Neuropsychopharmacol; 2010 Apr; 20(4):276-9. PubMed ID: 20133108
[TBL] [Abstract][Full Text] [Related]
10. Refill rate of antipsychotic drugs: an easy and inexpensive method to monitor patients' compliance by using computerised pharmacy data.
Rijcken CA; Tobi H; Vergouwen AC; de Jong-van den Berg LT
Pharmacoepidemiol Drug Saf; 2004 Jun; 13(6):365-70. PubMed ID: 15170765
[TBL] [Abstract][Full Text] [Related]
11. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
12. Checking the plausibility of psychiatrists׳ arguments for not prescribing depot medication.
Hamann J; Kissling W; Heres S
Eur Neuropsychopharmacol; 2014 Sep; 24(9):1506-10. PubMed ID: 25037772
[TBL] [Abstract][Full Text] [Related]
13. [Compliance in the treatment of schizophrenia -- results of an expert survey in Saxony and Saxony-Anhalt].
Giessler A; Born A; Helm H; Puschner B; Becker T
Psychiatr Prax; 2005 Oct; 32(7):349-57. PubMed ID: 16220419
[TBL] [Abstract][Full Text] [Related]
14. Patients' and psychiatrists' perceptions of clinical decisions during schizophrenia treatment.
Hamann J; Mendel RT; Fink B; Pfeiffer H; Cohen R; Kissling W
J Nerv Ment Dis; 2008 Apr; 196(4):329-32. PubMed ID: 18414128
[TBL] [Abstract][Full Text] [Related]
15. Psychiatrists' attitudes to maintenance medication for patients with schizophrenia.
Patel MX; Nikolaou V; David AS
Psychol Med; 2003 Jan; 33(1):83-9. PubMed ID: 12537039
[TBL] [Abstract][Full Text] [Related]
16. Combined treatment with amisulpride in patients with schizophrenia discharged from a short-term hospitalization unit: a 1-year retrospective study.
Molina JD; Lerma-Carrillo I; Leonor M; Pascual F; Blasco-Fontecilla H; González-Parra S; López-Muñoz F; Alamo C
Clin Neuropharmacol; 2009; 32(1):10-5. PubMed ID: 18978498
[TBL] [Abstract][Full Text] [Related]
17. Clinicians' attitudes toward the use of long-acting injectable antipsychotics.
Samalin L; Charpeaud T; Blanc O; Heres S; Llorca PM
J Nerv Ment Dis; 2013 Jul; 201(7):553-9. PubMed ID: 23817151
[TBL] [Abstract][Full Text] [Related]
18. [Assessment of therapeutic adherence using questionnaires in patients with schizophrenia].
István B; Agnes M
Psychiatr Hung; 2006; 21(6):430-6. PubMed ID: 17438660
[TBL] [Abstract][Full Text] [Related]
19. Attitudes of psychiatrists toward antipsychotic depot medication.
Heres S; Hamann J; Kissling W; Leucht S
J Clin Psychiatry; 2006 Dec; 67(12):1948-53. PubMed ID: 17194274
[TBL] [Abstract][Full Text] [Related]
20. Early hospital experience with fluphenazine decanoate.
Small JG; Kellams J
Dis Nerv Syst; 1974 Oct; 35(10):453-6. PubMed ID: 17894058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
